Citigroup’s Dianthus Therapeutics DNTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$217K Sell
11,670
-23,150
-66% -$431K ﹤0.01% 3306
2025
Q1
$632K Buy
34,820
+4,278
+14% +$77.6K ﹤0.01% 2823
2024
Q4
$666K Buy
30,542
+13,148
+76% +$287K ﹤0.01% 2839
2024
Q3
$476K Buy
17,394
+11,309
+186% +$310K ﹤0.01% 3020
2024
Q2
$157K Sell
6,085
-16,651
-73% -$431K ﹤0.01% 3286
2024
Q1
$682K Buy
22,736
+5,329
+31% +$160K ﹤0.01% 2639
2023
Q4
$181K Buy
17,407
+13,539
+350% +$141K ﹤0.01% 3217
2023
Q3
$52.9K Buy
+3,868
New +$52.9K ﹤0.01% 3427
2023
Q1
Sell
-46
Closed -$291 4788
2022
Q4
$291 Buy
46
+2
+5% +$13 ﹤0.01% 4764
2022
Q3
$1K Sell
44
-30
-41% -$682 ﹤0.01% 4791
2022
Q2
$1K Sell
74
-74
-50% -$1K ﹤0.01% 5197
2022
Q1
$7K Sell
148
-439
-75% -$20.8K ﹤0.01% 4881
2021
Q4
$42K Buy
587
+186
+46% +$13.3K ﹤0.01% 4378
2021
Q3
$47K Buy
401
+91
+29% +$10.7K ﹤0.01% 4017
2021
Q2
$48K Buy
310
+89
+40% +$13.8K ﹤0.01% 4172
2021
Q1
$42K Sell
221
-193
-47% -$36.7K ﹤0.01% 4131
2020
Q4
$52K Buy
414
+97
+31% +$12.2K ﹤0.01% 4076
2020
Q3
$34K Buy
317
+23
+8% +$2.47K ﹤0.01% 3682
2020
Q2
$35K Sell
294
-282
-49% -$33.6K ﹤0.01% 3927
2020
Q1
$58K Buy
576
+146
+34% +$14.7K ﹤0.01% 3675
2019
Q4
$104K Buy
430
+307
+250% +$74.3K ﹤0.01% 3521
2019
Q3
$20K Sell
123
-274
-69% -$44.6K ﹤0.01% 4274
2019
Q2
$94K Buy
397
+127
+47% +$30.1K ﹤0.01% 3676
2019
Q1
$71K Buy
270
+243
+900% +$63.9K ﹤0.01% 3797
2018
Q4
$2K Sell
27
-44
-62% -$3.26K ﹤0.01% 4877
2018
Q3
$14K Buy
+71
New +$14K ﹤0.01% 4630